Friday, February 10th at 12 PM EST / 9 AM PST
We are pleased to learn that the FDA has approved EMFLAZA (deflazacort). The FDA’s approval of EMFLAZA provides options for families when making decisions about care with their providers. During this webinar, the Marathon team will provide information about EMFLAZA’s FDA-approved label, patient support services, and access to this medication.
This webinar is hosted by PPMD. For those who cannot make the call, it will be recorded and made available on the PPMD website until Friday, February 24th, as directed by Marathon. As always, it is best to talk to your physician regarding your medical care.